Uncover key drivers, emerging technologies, and competitive movements shaping the dog vaccines market from 2025–2034 with trusted insights from The Business Research Company
What Is The Present Size Of The Dog Vaccines Market And What Value Is Projected For 2029?
The valuation for the canine vaccination sector has experienced a robust upward trend recently, projected to advance from $3.61 billion in the current year of 2024 to reach $3.8 billion by 2025, reflecting a compound annual growth rate amounting to 5.3%; this past period’s expansion was propelled by factors such as the introduction of novel immunization regimens, increased public consciousness regarding diseases transmissible from animals to humans, the expanding phenomenon of worldwide connectivity and associated travel, ongoing informational efforts, advancements in vaccine research and subsequent creation, and the ongoing transformation within veterinary medical practices.
Anticipating robust expansion, the canine immunizations sector is on course to reach a valuation of $5.05 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.4% over the projected timeframe, a surge fueled by greater pet ownership, heightened awareness of animal wellness, governmental directives, the trend of treating pets as family members, and the widespread incidence of dog illnesses; concurrently, key developments shaping this market include the proliferation of pet health coverage, easier availability of vaccines, tailored immunization schedules, shifts in how diseases manifest, and the introduction of innovative vaccine products.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8443&type=smp
What Factors Are Boosting The Dog Vaccines Market?
Growing acceptance of canines as household companions is anticipated to be a major force boosting the market for dog vaccinations in the future. Companion dogs, essentially domesticated or tamed animals residing in human dwellings, are increasing in number. A canine vaccine constitutes an administered injection, typically sequenced from puppyhood right through maturity, designed to activate the animal’s immune response, enabling it to confront pathogens with reduced or mitigated illness. To illustrate this trend, data from the American Pet Products Association’s 2021-2022 National Pet Owners Survey indicates that 70 percent of American homes housed at least one pet, equating to 90.5 million residences; notably, dogs were the most commonly kept pets, present in 69 million US households, outstripping all other animal categories. Consequently, the escalating prevalence of dog ownership directly fuels the expansion of the dog vaccine sector.
What Are The Core Segmentation Criteria In The Dog Vaccines Market?
The dog vaccines market covered in this report is segmented –
1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months
Subsegments:
1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine, Canine Distemper Vaccine, Canine Adenovirus Vaccine
2) By Conjugate Vaccines: Canine Leptospira Vaccine, Canine Bordetella Vaccine
3) By Inactivated Vaccines: Canine Parvovirus Vaccine, Canine Influenza Vaccine
4) By Subunit Vaccines: Canine Lyme Disease Vaccine, Canine Parainfluenza Vaccine
5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine
6) By DNA Vaccines: Canine Melanoma Vaccine
7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine, Canine Bordetella Recombinant Vaccine
Which Emerging Trends Are Reshaping The Dog Vaccines Market Landscape?
A principal factor influencing the dog vaccines sector is the trend of technological progress, with prominent market participants increasingly focusing on deploying innovative techniques in creating new vaccines; specifically, in September 2022, Merck Animal Health, a US entity offering animal health products including pharmaceuticals, vaccines, and technological systems, introduced Nobivac Intra-Trac Oral BbPi, which stands out as the inaugural oral vaccine providing mucosal defense and simple administration via the mouth, designed to immunize healthy dogs seven weeks of age and above against both the canine parainfluenza virus and Bordetella bronchiseptica, incorporating the groundbreaking Immuno-Mist-R technology developed by Intervet, an affiliate of Merck & Co, which serves to significantly augment the contact surface area of mucosal tissues.
Which Players Are Shaping The Competitive Landscape Of The Dog VaccinesXX Market?
Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report
What Regional Trends Are Shaping Growth In The Dog Vaccines Market?
Asia-Pacific was the largest region in the dog vaccines market in 2024. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=8443&type=smp
Browse Through More Reports Similar to the Global Dog Vaccines Market 2025, By The Business Research Company
Veterinary Medical Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report
Veterinary Anesthesia Equipment Global Market Report 2025
Veterinary Patient Monitoring Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
